| Bioactivity | Cortistatin-29 (human) is a somatostatin neuropeptide with potential for studying diseases such as cancer, inflammation, autoimmunity, fibrosis, and pain[1][2]. |
| Name | Cortistatin-29 (human) |
| CAS | 1815618-16-6 |
| Sequence | {Pyr}-Glu-Gly-Ala-Pro-Pro-Gln-Gln-Ser-Ala-Arg-Arg-Asp-Arg-Met-Pro-Cys-Arg-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Ser-Ser-Cys-Lys (Disulfide bridge: Cys17-Cys28) |
| Shortening | {Pyr}-EGAPPQQSARRDRMPCRNFFWKTFSSCK (Disulfide bridge: Cys17-Cys28) |
| Formula | C149H223N47O42S3 |
| Molar Mass | 3440.85 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Spier AD, et al. Cortistatin: a member of the somatostatin neuropeptide family with distinct physiological functions. Brain Res Brain Res Rev. 2000 Sep;33(2-3):228-41. [2]. Campos-Salinas J, et al. Therapeutic Effect of a Latent Form of Cortistatin in Experimental Inflammatory and Fibrotic Disorders. Pharmaceutics. 2022 Dec 13;14(12):2785. |
Cortistatin-29 (human)
CAS: 1815618-16-6 F: C149H223N47O42S3 W: 3440.85
Cortistatin-29 (human) is a somatostatin neuropeptide with potential for studying diseases such as cancer, inflammation,
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.